Onset of secondary progressive MS after long‐term rituximab therapy – a case report

A patient with relapsing multiple sclerosis (RMS) was treated with a standard immunomodulatory therapy, but due to ongoing disease activity was switched to rituximab. Relapses ceased, but secondary progressive MS (SPMS) eventually appeared, associated with new focal spinal cord white matter lesions....

Descripción completa

Detalles Bibliográficos
Autores principales: von Büdingen, H.‐Christian, Bischof, Antje, Eggers, Erica L., Wang, Shengzhi, Bevan, Carolyn J., Cree, Bruce A. C., Henry, Roland G., Hauser, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221476/
https://www.ncbi.nlm.nih.gov/pubmed/28078314
http://dx.doi.org/10.1002/acn3.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221476/
https://www.ncbi.nlm.nih.gov/pubmed/28078314
http://dx.doi.org/10.1002/acn3.377

Ejemplares similares